Simcere Pharmaceutical Group Limited
SMHGF
$0.6697
-$0.0641-8.74%
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.86% | -3.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.86% | -3.01% | |||
| Cost of Revenue | -0.86% | -18.66% | |||
| Gross Profit | -0.86% | 2.19% | |||
| SG&A Expenses | -0.86% | 3.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.86% | -5.44% | |||
| Total Operating Expenses | -0.86% | -11.51% | |||
| Operating Income | -0.86% | 66.49% | |||
| Income Before Tax | -0.86% | 131.39% | |||
| Income Tax Expenses | -0.86% | 251.68% | |||
| Earnings from Continuing Operations | -0.86% | 129.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.86% | 129.44% | |||
| EBIT | -0.86% | 66.49% | |||
| EBITDA | -0.86% | 52.04% | |||
| EPS Basic | -0.80% | 130.05% | |||
| Normalized Basic EPS | -1.01% | 73.68% | |||
| EPS Diluted | -0.80% | 130.05% | |||
| Normalized Diluted EPS | -1.01% | 73.68% | |||
| Average Basic Shares Outstanding | 0.00% | -1.77% | |||
| Average Diluted Shares Outstanding | 0.00% | -1.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||